Therefore, it would be crucial to understand and outline the specific contribution of each cell type – MN, glia, or others – to ALS, in order to strategically target them with the NRF2 activators, thereby restoring neuronal homeostasis and survival, and functional MN-glia interactions (Fig. 6). The gene discussed is NFE2L2; the disease is amyotrophic lateral sclerosis.